Drug Landscape ›
F-18 FDG ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 27
Most-reported reactions
Feeling Hot — 8 reports (29.63%) Hyperhidrosis — 8 reports (29.63%) Asthenia — 2 reports (7.41%) Hypertension — 2 reports (7.41%) Sinus Node Dysfunction — 2 reports (7.41%) Blood Pressure Abnormal — 1 report (3.7%) Cold Sweat — 1 report (3.7%) Cytokine Release Syndrome — 1 report (3.7%) Lethargy — 1 report (3.7%) Tremor — 1 report (3.7%)
Source database →
F-18 FDG in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is F-18 FDG approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for F-18 FDG in United States?
Mayo Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.